Allarity Therapeutics Granted FDA Fast Track Designation for Stenoparib for the Treatment of Advanced Ovarian Cancer Nanotech Investing
Caribou Biosciences to Participate in the Citi 2025 Biopharma Back to School Conference Nanotech Investing
Anixa Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference Nanotech Investing
Silo Pharma's Alzheimer's Candidate SPC-14 Featured in Leading Scientific Peer-reviewed Journal Nanotech Investing
Satellos to Participate in Four September Institutional and Retail Investor Conferences Nanotech Investing
Longeveron® to Present at the H.C. Wainwright 27th Annual Global Investment Conference Nanotech Investing
Anixa Biosciences Receives Notice of Allowance from Chinese National Intellectual Property Administration for Patent Covering Breast Cancer Vaccine Technology Nanotech Investing
Silo Pharma's PTSD Candidate SPC-15 Achieves Positive Safety Milestone, Paving Way for Accelerated Clinical Trials Under 505 Pathway Nanotech Investing
Anixa Biosciences Announces Treatment of Second Patient in Fourth Cohort of Ovarian Cancer CAR-T Clinical Trial Nanotech Investing
Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships Nanotech Investing
